BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 12604440)

  • 21. Miconazole creams for fungal and candida infections.
    Drug Ther Bull; 1975 Sep; 13(20):79-80. PubMed ID: 1183317
    [No Abstract]   [Full Text] [Related]  

  • 22. Barrier methods.
    Tyrer LB; Bradshaw LE
    Clin Obstet Gynaecol; 1979 Apr; 6(1):39-55. PubMed ID: 383350
    [No Abstract]   [Full Text] [Related]  

  • 23. [Treatment with E ovules in postmenopausal colpocystopathies].
    Pricop F; Teleman G; Buţureanu S; Căzănaru R; Gafiţanu E; Popovici I
    Rev Med Chir Soc Med Nat Iasi; 1987; 91(2):353-5. PubMed ID: 3685702
    [No Abstract]   [Full Text] [Related]  

  • 24. Conjugated estrogens (Premarin) vaginal cream.
    Med Lett Drugs Ther; 2009 Feb; 51(1306):14-5. PubMed ID: 19229162
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Therapeutic principles in vulvovaginal dermatology.
    Beecker J
    Dermatol Clin; 2010 Oct; 28(4):639-48. PubMed ID: 20883909
    [TBL] [Abstract][Full Text] [Related]  

  • 26. By the way, doctor. Most of your hormone articles are about Premarin, made from the urine of pregnant horses, combined with Provera, an artificial progesterone. My pharmacist compounds a natural cream for me, using hormones identical to mine, and I swear by it. What's your opinion?
    Robb-Nicholson C
    Harv Womens Health Watch; 2003 Oct; 11(2):8. PubMed ID: 14576012
    [No Abstract]   [Full Text] [Related]  

  • 27. Management of vaginal dryness and dyspareunia in estrogen sensitive cancer patients.
    Del Pup L
    Gynecol Endocrinol; 2012 Sep; 28(9):740-5. PubMed ID: 22409649
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Postpartum vaginal agglutination: a case report.
    Howard TF; Lewicky-Gaupp C
    Female Pelvic Med Reconstr Surg; 2012; 18(3):188-9. PubMed ID: 22543776
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vaginal delivery of contraceptives.
    Sitruk-Ware R
    Expert Opin Drug Deliv; 2005 Jul; 2(4):729-36. PubMed ID: 16296797
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Anticonception of youth (author's transl)].
    Seibold H
    Ther Umsch; 1976 Apr; 33(4):257-60. PubMed ID: 1006582
    [No Abstract]   [Full Text] [Related]  

  • 31. Preventing disease by protecting the cervix: the unexplored promise of internal vaginal barrier devices.
    Moench TR; Chipato T; Padian NS
    AIDS; 2001 Sep; 15(13):1595-602. PubMed ID: 11546933
    [No Abstract]   [Full Text] [Related]  

  • 32. I have found vaginal estrogen cream to be very effective for vaginal dryness but am concerned about the long-term effects of using it. Are there any other treatments that work well for this?
    Robb-Nicholson C
    Harv Womens Health Watch; 1998 Mar; 5(7):7. PubMed ID: 9552198
    [No Abstract]   [Full Text] [Related]  

  • 33. Tetracycline and amphotericin B vaginal cream for mixed vaginal infections.
    Rubin A; Whitcomb M; Russell M; Amod ND
    S Afr Med J; 1983 Mar; 63(11):395-7. PubMed ID: 6828943
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Indications for and practical aspects of intravaginal estrogen therapy using dienoestrol ortho-vaginal cream].
    Korte W
    Fortschr Med; 1973 Aug; 91(22):921-8. PubMed ID: 4744899
    [No Abstract]   [Full Text] [Related]  

  • 35. Predictors of urinary tract infection after menopause: a prospective study.
    Jackson SL; Boyko EJ; Scholes D; Abraham L; Gupta K; Fihn SD
    Am J Med; 2004 Dec; 117(12):903-11. PubMed ID: 15629728
    [TBL] [Abstract][Full Text] [Related]  

  • 36. By the way, doctor. My doctor prescribed a low-dose vaginal estrogen cream, applied twice a week, for atrophic vaginitis. I've heard this dose is so low that it carries no health risk. Do you agree?
    Robb-Nicholson C
    Harv Womens Health Watch; 2007 Nov; 15(3):7. PubMed ID: 18225330
    [No Abstract]   [Full Text] [Related]  

  • 37. Topical estrogen therapy in the management of postmenopausal vaginal atrophy: an up-to-date overview.
    Al-Baghdadi O; Ewies AA
    Climacteric; 2009 Apr; 12(2):91-105. PubMed ID: 19117185
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative effects of a contraceptive vaginal ring delivering a nonandrogenic progestin and continuous ethinyl estradiol and a combined oral contraceptive containing levonorgestrel on hemostasis variables.
    Rad M; Kluft C; Ménard J; Burggraaf J; de Kam ML; Meijer P; Sivin I; Sitruk-Ware RL
    Am J Obstet Gynecol; 2006 Jul; 195(1):72-7. PubMed ID: 16545330
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Superior cycle control with a contraceptive vaginal ring compared with an oral contraceptive containing 30 microg ethinylestradiol and 150 microg levonorgestrel: a randomized trial.
    Oddsson K; Leifels-Fischer B; Wiel-Masson D; de Melo NR; Benedetto C; Verhoeven CH; Dieben TO
    Hum Reprod; 2005 Feb; 20(2):557-62. PubMed ID: 15539438
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Randomized comparison of tolterodine with vaginal estrogen cream versus tolterodine alone for the treatment of postmenopausal women with overactive bladder syndrome.
    Tseng LH; Wang AC; Chang YL; Soong YK; Lloyd LK; Ko YJ
    Neurourol Urodyn; 2009; 28(1):47-51. PubMed ID: 19089890
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.